This is not specific to tirzepatide or AOD 9604 but rather a consequence of rapid weight loss itself, known as telogen effluvium
Professor Ngs research contributions to AOD-9604 development include: Synthesis and characterization of the modified C-terminal growth hormone fragment with enhanced stability Design of the tyrosine N-terminal modification to improve peptide stability and half-life Preclinical studies demonstrating lipolytic effects in obese animal models Advancement of the peptide through multiple phases of clinical development Investigation of mechanisms underlying beta-3-adrenergic receptor modulation His work established the foundation for understanding peptide-based approaches to metabolic regulation, though clinical translation ultimately proved unsuccessful
Discuss any concerns with your healthcare provider
This protects you from accidental exposure and helps maintain the sterility of your research materials
MOTS-c is a mitochondrial-derived peptide that activates AMPK, the same metabolic switch exercise and fasting flip, improving insulin sensitivity, mitochondrial function, and metabolic flexibility
This material is not a drug, food, cosmetic, dietary supplement, or medical device and has not been evaluated by the FDA